A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations
Clinical trial NCT06500676 · RECRUITING
Trial details
- NCT number
- NCT06500676
- Sponsor
- Genfleet Therapeutics (Shanghai) Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-09
- Primary completion
- 2028-07-31
- Enrollment
- 407
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.